The FH Foundation is pleased to support  the efforts of our research partners in the field of FH. 

Please note this opportunity below:
Dear Colleague,
 
Are you or any of your collaborators involved in PCSK9-related research and looking for funding to support your work?
 
The   ASPIRE CV Competitive Research Grant Program,  an independent competitive grants program supported by Pfizer, is awarding individual grants of up to US $200,000 from a total fund of US $2 million to support projects which bring new insights or advance the understanding of the role of the PCSK9 protein/gene in health and disease.
 
Detailed information on the ASPIRE CV Awards program will be available via
 https://www.aspireresearch.org/cardiovascular/index.html from February 5, 2016.  
 
Letter of Intent (LOI) application deadline: March 13, 2016
 
 
Kind regards, 
 

Katherine Wilemon on behalf of the ASPIRE Cardiovascular Competitive Research Grant Award Program 



STAY CONNECTED: